Trypanosoma brucei CTP synthetase: a target for the treatment of African sleeping sickness.Show others and affiliations
2001 (English)In: Proceedings of the National Academy of Sciences of the U S A, ISSN 0027-8424, Vol. 98, no 11, p. 6412-6Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2001. Vol. 98, no 11, p. 6412-6
Keywords [en]
Adenosine Triphosphate/metabolism, Animals, Carbon-Nitrogen Ligases/*antagonists & inhibitors, Cells; Cultured, Cytidine/pharmacology, Cytidine Triphosphate/biosynthesis/metabolism, Diazooxonorleucine/*pharmacology/therapeutic use, Enzyme Inhibitors/*pharmacology/therapeutic use, Fibroblasts/cytology, Guanine/pharmacology, Guanosine Triphosphate/metabolism, Humans, Hypoxanthines/pharmacology, Intracellular Fluid, Isoxazoles/*pharmacology/therapeutic use, Mice, Mice; Inbred BALB C, Trypanocidal Agents/*pharmacology/therapeutic use, Trypanosoma brucei brucei/drug effects/*enzymology/growth & development, Trypanosomiasis; African/blood/*drug therapy/parasitology, Uridine Triphosphate/metabolism
Identifiers
URN: urn:nbn:se:umu:diva-9176PubMedID: 11353848Scopus ID: 2-s2.0-0035933201OAI: oai:DiVA.org:umu-9176DiVA, id: diva2:148847
2008-03-072008-03-072023-03-23Bibliographically approved